| A randomized trial of bevacizumab for newly diagnosed glioblastoma MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ... New England Journal of Medicine 370 (8), 699-708, 2014 | 2977 | 2014 |
| Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial EL Chang, JS Wefel, KR Hess, PK Allen, FF Lang, DG Kornguth, ... The lancet oncology 10 (11), 1037-1044, 2009 | 2597 | 2009 |
| Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ... Journal of clinical oncology 31 (32), 4085-4091, 2013 | 1075 | 2013 |
| International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer JS Wefel, J Vardy, T Ahles, SB Schagen The lancet oncology 12 (7), 703-708, 2011 | 977 | 2011 |
| Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ... Neuro-oncology 15 (10), 1429-1437, 2013 | 923 | 2013 |
| The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial JS Wefel, R Lenzi, RL Theriault, RN Davis, CA Meyers Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 840 | 2004 |
| Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system VA Levin, L Bidaut, P Hou, AJ Kumar, JS Wefel, BN Bekele, S Prabhu, ... International Journal of Radiation Oncology* Biology* Physics 79 (5), 1487-1495, 2011 | 762 | 2011 |
| Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001 PD Brown, V Gondi, S Pugh, WA Tome, JS Wefel, TS Armstrong, JA Bovi, ... Journal of Clinical Oncology 38 (10), 1019-1029, 2020 | 643 | 2020 |
| Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer JS Wefel, AK Saleeba, AU Buzdar, CA Meyers Cancer 116 (14), 3348-3356, 2010 | 617 | 2010 |
| Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas MJ van den Bent, JS Wefel, D Schiff, MJB Taphoorn, K Jaeckle, L Junck, ... The lancet oncology 12 (6), 583-593, 2011 | 612 | 2011 |
| Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults JS Wefel, SR Kesler, KR Noll, SB Schagen CA: a cancer journal for clinicians 65 (2), 123-138, 2015 | 517 | 2015 |
| Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non–small-cell lung cancer JW Welsh, R Komaki, A Amini, MF Munsell, W Unger, PK Allen, JY Chang, ... Journal of Clinical Oncology 31 (7), 895-902, 2013 | 485 | 2013 |
| Chemotherapy-related cognitive dysfunction JS Wefel, SB Schagen Current neurology and neuroscience reports 12, 267-275, 2012 | 444 | 2012 |
| Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop J Vardy, JS Wefel, T Ahles, IF Tannock, SB Schagen Annals of Oncology 19 (4), 623-629, 2008 | 438 | 2008 |
| ‘Chemobrain’in breast carcinoma? A prologue JS Wefel, R Lenzi, R Theriault, AU Buzdar, S Cruickshank, CA Meyers Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 436 | 2004 |
| Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy J Dietrich, M Monje, J Wefel, C Meyers The oncologist 13 (12), 1285-1295, 2008 | 404 | 2008 |
| The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity CA Meyers, JS Wefel Journal of Clinical Oncology 21 (19), 3557-3558, 2003 | 274 | 2003 |
| Whole-brain radiotherapy for brain metastases: evolution or revolution? PD Brown, MS Ahluwalia, OH Khan, AL Asher, JS Wefel, V Gondi Journal of Clinical Oncology 36 (5), 483-491, 2018 | 204 | 2018 |
| Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target JS Wefel, AE Kayl, CA Meyers British Journal of Cancer 90 (9), 1691-1696, 2004 | 202 | 2004 |
| Memory performance after head injury: Contributions of malingering, litigation status, psychological factors, and medication use J Suhr, D Tranel, J Wefel, J Barrash Journal of clinical and experimental neuropsychology 19 (4), 500-514, 1997 | 200 | 1997 |
